AKT1 and endothelial dysfunction: Targeting key downstream pathways such as TGF-β, PI3K/Akt, NF-κB, and MAPKs opens a dynamic avenue for mitigating vascular remodeling by reversing endothelial dysfunction in PAECs, tackling excessive proliferation in PASMCs, inhibiting ECM remodeling in PAFs as thoroughly reviewed.